Literature DB >> 22950983

Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Suresh Kumar Gorla1, Mandapati Kavitha, Minjia Zhang, Xiaoping Liu, Lisa Sharling, Deviprasad R Gollapalli, Boris Striepen, Lizbeth Hedstrom, Gregory D Cuny.   

Abstract

Cryptosporidium parvum and related species are zoonotic intracellular parasites of the intestine. Cryptosporidium is a leading cause of diarrhea in small children around the world. Infection can cause severe pathology in children and immunocompromised patients. This waterborne parasite is resistant to common methods of water treatment and therefore a prominent threat to drinking and recreation water even in countries with strong water safety systems. The drugs currently used to combat these organisms are ineffective. Genomic analysis revealed that the parasite relies solely on inosine-5'-monophosphate dehydrogenase (IMPDH) for the biosynthesis of guanine nucleotides. Herein, we report a selective urea-based inhibitor of C. parvum IMPDH (CpIMPDH) identified by high-throughput screening. We performed a SAR study of these inhibitors with some analogues exhibiting high potency (IC(50) < 2 nM) against CpIMPDH, excellent selectivity >1000-fold versus human IMPDH type 2 and good stability in mouse liver microsomes. A subset of inhibitors also displayed potent antiparasitic activity in a Toxoplasma gondii model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22950983      PMCID: PMC3635066          DOI: 10.1021/jm3007917

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

Review 1.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.

Authors:  Dennis A Smith; Li Di; Edward H Kerns
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

2.  Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.

Authors:  Adrien Boularot; Carmela Giglione; Sylvain Petit; Yann Duroc; Rodolphe Alves de Sousa; Valéry Larue; Thierry Cresteil; Frédéric Dardel; Isabelle Artaud; Thierry Meinnel
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

3.  Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.

Authors:  Sivapriya Kirubakaran; Suresh Kumar Gorla; Lisa Sharling; Minjia Zhang; Xiaoping Liu; Soumya S Ray; Iain S Macpherson; Boris Striepen; Lizbeth Hedstrom; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2012-01-24       Impact factor: 2.823

Review 4.  An updated review on Cryptosporidium and Giardia.

Authors:  David B Huang; A Clinton White
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

5.  Genetic complementation in apicomplexan parasites.

Authors:  Boris Striepen; Michael W White; Catherine Li; Michael N Guerini; S-Banoo Malik; John M Logsdon; Chang Liu; Mitchell S Abrahamsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

7.  Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques.

Authors:  S S R Ajjampur; P Rajendran; S Ramani; I Banerjee; B Monica; P Sankaran; V Rosario; R Arumugam; R Sarkar; H Ward; G Kang
Journal:  J Med Microbiol       Date:  2008-11       Impact factor: 2.472

8.  Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.

Authors:  Nwakaso N Umejiego; Catherine Li; Thomas Riera; Lizbeth Hedstrom; Boris Striepen
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.

Authors:  Nwakaso N Umejiego; Deviprasad Gollapalli; Lisa Sharling; Anna Volftsun; Jennifer Lu; Nicole N Benjamin; Adam H Stroupe; Thomas V Riera; Boris Striepen; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2008-01

10.  Facile production of mono-substituted urea side chains in solid phase peptide synthesis.

Authors:  Maria L Diss; Alan J Kennan
Journal:  Biopolymers       Date:  2007-07       Impact factor: 2.505

View more
  23 in total

1.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.

Authors:  Suresh Kumar Gorla; Yan Zhang; Meaghan M Rabideau; Aiping Qin; Shibin Chacko; Amanda L House; Corey R Johnson; Kavitha Mandapati; Hannah M Bernstein; Elizabeth S McKenney; Helena Boshoff; Minjia Zhang; Ian J Glomski; Joanna B Goldberg; Gregory D Cuny; Barbara J Mann; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 3.  Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.

Authors:  Kapil Juvale; Althaf Shaik; Sivapriya Kirubakaran
Journal:  Medchemcomm       Date:  2019-05-02       Impact factor: 3.597

4.  Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.

Authors:  Kavitha Mandapati; Suresh Kumar Gorla; Amanda L House; Elizabeth S McKenney; Minjia Zhang; Suraj Nagendra Rao; Deviprasad R Gollapalli; Barbara J Mann; Joanna B Goldberg; Gregory D Cuny; Ian J Glomski; Lizbeth Hedstrom
Journal:  ACS Med Chem Lett       Date:  2014-06-10       Impact factor: 4.345

5.  A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.

Authors:  Kehinde F Omolabi; Emmanuel A Iwuchukwu; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2021-01-09       Impact factor: 1.810

6.  Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.

Authors:  Corey R Johnson; Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; Xiaoping Liu; Boris Striepen; Jan R Mead; Gregory D Cuny; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

Review 7.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.

Authors:  Yang Wei; Petr Kuzmič; Runhan Yu; Gyan Modi; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

9.  Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.

Authors:  Kehinde F Omolabi; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  Cell Biochem Biophys       Date:  2020-10-15       Impact factor: 2.194

10.  Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Authors:  Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; James En Wai Chin; Xiaoping Liu; Boris Striepen; Magdalena Makowska-Grzyska; Youngchang Kim; Andrzej Joachimiak; Lizbeth Hedstrom; Gregory D Cuny
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.